MedTrace Logo

Citrulline Supplementation On Vascular Responsiveness and Function in Postmenopausal Women

NCT05600413 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 26

Last updated 2022-10-31

No results posted yet for this study

Summary

The objective of this project is to provide evidence that L-Citrulline (L-CIT) supplementation can improve vascular function at rest and in response to exercise in postmenopausal women.

Conditions

Interventions

DIETARY_SUPPLEMENT

L-Citrulline

4 weeks of L-Citrulline supplementation (6 grams/day)

DIETARY_SUPPLEMENT

Placebo

4 weeks of Placebo (crystalline cellulose)

Sponsors & Collaborators

  • Texas Tech University

    lead OTHER

Principal Investigators

  • Arturo Figueroa · Texas Tech University

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
79 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-07-07
Primary Completion
2022-04-27
Completion
2022-04-27

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05600413 on ClinicalTrials.gov